Literature DB >> 6143085

Fluctuating islet-cell autoimmunity in unaffected relatives of patients with insulin-dependent diabetes.

K M Spencer, A Tarn, B M Dean, J Lister, G F Bottazzo.   

Abstract

Complement-fixing islet-cell antibodies (CF-ICA) were found in 20 out of 685 unaffected first-degree relatives of children with type 1 diabetes. During a 5-year follow-up, 7 of the 20 became diabetic, 1 continued to show the antibodies without any abnormality of glucose tolerance, and 12 subjects lost them without the disease developing. Although CF-ICA are useful as a marker of active insulitis they should not at present be used to define subjects who might benefit from preventive immunosuppression.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6143085     DOI: 10.1016/s0140-6736(84)91278-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  22 in total

Review 1.  Prediction and prevention of type I diabetes.

Authors:  R Gianani; G S Eisenbarth
Journal:  J Endocrinol Invest       Date:  1994 Jul-Aug       Impact factor: 4.256

Review 2.  Markers for insulin dependent diabetes: towards early detection.

Authors:  T Wilkin; M Armitage
Journal:  Br Med J (Clin Res Ed)       Date:  1986-11-22

3.  Islet cell and insulin autoantibodies in subjects at high risk for development of type 1 (insulin-dependent) diabetes mellitus: the Lyon family study.

Authors:  C Thivolet; B Beaufrére; H Bétuel; L Gebuhrer; P Chatelain; A Durand; J Tourniaire; R François
Journal:  Diabetologia       Date:  1988-10       Impact factor: 10.122

4.  Auto-immunity in children with diabetes mellitus and in their relatives.

Authors:  R Lorini; D Larizza; C Livieri; V Cammareri; A Martini; A Plebani; D Zanaboni; F Severi
Journal:  Eur J Pediatr       Date:  1986-08       Impact factor: 3.183

5.  Islet cell antibodies in the Japanese population and subjects with type 1 (insulin-dependent) diabetes.

Authors:  K Notsu; N Oka; S Note; N Nabeya; S Kuno; T Sakurami
Journal:  Diabetologia       Date:  1985-09       Impact factor: 10.122

6.  Islet-cell antibodies as predictors of the later development of type 1 (insulin-dependent) diabetes. A study in identical twins.

Authors:  C Johnston; B A Millward; P Hoskins; R D Leslie; G F Bottazzo; D A Pyke
Journal:  Diabetologia       Date:  1989-06       Impact factor: 10.122

Review 7.  The role of immunotherapy in type I diabetes mellitus.

Authors:  M E Geffner; B M Lippe
Journal:  West J Med       Date:  1987-03

8.  Autoantibodies and genetic factors associated with the development of type 1 (insulin-dependent) diabetes mellitus in first degree relatives of diabetic patients.

Authors:  C Thivolet; B Beaufrère; L Geburher; P Chatelain; J Orgiazzi; R François
Journal:  Diabetologia       Date:  1991-03       Impact factor: 10.122

9.  Five-year follow-up of islet cell antibodies in type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  L Niskanen; J Karjalainen; H Sarlund; O Siitonen; M Uusitupa
Journal:  Diabetologia       Date:  1991-06       Impact factor: 10.122

10.  Risk for developing type 1 (insulin-dependent) diabetes mellitus and the presence of islet 64K antibodies.

Authors:  H Bärmeier; D K McCulloch; J L Neifing; G Warnock; R V Rajotte; J P Palmer; A Lernmark
Journal:  Diabetologia       Date:  1991-10       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.